Some new drugs aren’t actually ‘new’ – pharmaceutical companies exploit patents and raise prices for patients, but data transparency can help protect innovation
By Lucy Xiaolu Wang, Assistant Professor, Department of Resource Economics, UMass Amherst
By extending their monopoly on a drug, companies prevent generics and other competitors from driving down prices. But increasing transparency can help prevent Big Pharma from gaming the patent system.
Read complete article
© The Conversation
-
Tuesday, September 23, 2025